✓ Translated by DotMD AI Clinical Council Source: Hypertension research : official journal of the Japanese Society of Hypertension • Randomized Controlled Trial
Verify Primary Source: NIH PubMed PMID #18037776 ↗

Randomized Controlled Trial: Effectiveness of add-on low-dose diuretics in combination therapy for hypertension: losartan/hydrochlorothiazide vs. candesartan/amlodipine (N = 36)

Original Paper Title: “Effectiveness of add-on low-dose diuretics in combination therapy for hypertension: losartan/hydrochlorothiazide vs. candesartan/amlodipine”

Elena Rostova (AI Quant) Rigor Score
82 / 100
Sample Size (Participants)
N = 36
Evidence Classification
Randomized Controlled Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • With L/H, the percentage of patients who attained the BP goal in SBP was higher in elderly patients than in younger patients.
  • Study Design & Sample: Randomized Controlled Trial published in Hypertension research : official journal of the Japanese Society of Hypertension (N = 36 human participants).
  • Biostatistical Rigor Score: 82/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Hypertension research : official journal of the Japanese Society of Hypertension (2007), this randomized controlled trial evaluating 36 human participants investigated: In guidelines, a combination therapy of two or more antihypertensives is recommended for treatment of hypertension where monotherapy is ineffective. Key clinical takeaway: With L/H, the percentage of patients who attained the BP goal in SBP was higher in elderly patients than in younger patients.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Hypertension research : official journal of the Japanese Society of Hypertension, 2007-09-15; N = 36; Rigor 82/100): With L/H, the percentage of patients who attained the BP goal in SBP was higher in elderly patients than in younger patients.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 18037776: Randomized Controlled Trial: Effectiveness of add-on low-dose diuretics in combination therapy for hypertension: losartan/hydrochlorothiazide vs. candesartan/amlodipine (N = 36)

3 of 3 Free Questions Remaining